Steven Hildemann

Steven Hildemann MD, PhD is a Physician Scientist serving as a Senior Vice President and Global Chief Medical Officer at Merck Biopharma, where he also leads Global Patient Safety (GPS) and the Global Chief Medical Office (CMO) responsible for Bioethics, Medical Governance among other. Steven is a board certified internist and cardiologist with broad clinical training in Internal Medicine including Medical Hematology and Oncology, Gastroenterology, Rheumatology, Pulmonology and Infectious Diseases at University Hospitals in Munich. He co-led multiple Clinical Trials among other scientific engagements with the biopharmaceutical industry as an advisor and OL. Steven´s professional career is dedicated to improving the lives of patients suffering from severe and life threatening diseases such as cancer, neurodegenerative diseases such as MS, autoimmune diseases as well as metabolic disorders such as diabetes, cardiovascular disease and heart failure. He has helped change the practice of medicine by co-developing and launching several innovative, life- saving drugs which are current guideline therapy globally. As an active Professor of Medicine and member of the Faculty of Medicine at the University of Freiburg Steven maintains clinical lecturing and regular patient centric bedside teaching of medical students and young physicians to complement his contributions to Merck Healthcare as the Global Chief Medical Officer – living “as one for patients”. Steven joined the pharmaceutical industry, 1998, in a country medical director role. He then contributed and served in roles of increasing responsibility at the local, regional and global level in Medical Affairs, Clinical Operations and Drug Safety. Through a series of large Biopharma acquisitions, Steven assumed local, regional und later global change leadership roles in major organisations such as Pharmacia, Pfizer, Schering-Plough and MSD, where he designed and fully implemented global organisations in Medical Affairs, Clinical Operations and Drug Safety. As Mercks Global CMO and a member or R&Ds executive leadership team Steven is committed to advancing our Healthcare Agenda as a science- and innovation based global specialty innovator through patient-centric leadership, sound medical governance and global business conduct at the highest bioethical standards. He contributes actively to Mercks external perception and impact consistent with these values.